NDC 66298-8507-04 - Moxifloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66298-8507
- Requested NDC
- 66298-8507-04
- Package NDCs from labels
- 66298-8507-4, 66298-8507-04
- Manufacturer
- Hp Halden Pharma AS
- Effective date
- 2024-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Moxifloxacin - Hp Halden Pharma AS | Hp Halden Pharma AS | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66298-8507-4 | Moxifloxacin | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66298-8507 | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) INJECTION, SOLUTION [HP HALDEN PHARMA AS] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240719_6067b2ee-2171-49bb-aa07-1d401ebf4f2e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxifloxacin | MOXIFLOXACIN HYDROCHLORIDE | Kesin Pharma Corportation | 5a6d3ff1-e853-a3d8-e063-6394a90a18f5 | 2026-11-06 | Boxed warning, Warnings, Adverse reactions | C53598599T |
| MOXIFLOXACIN | MOXIFLOXACIN | Sportpharm LLC | ab0c76cc-b4dd-49d1-b5c9-7af84b2ae5fa | 2026-10-31 | Warnings, Adverse reactions | C53598599T |
| Moxifloxacin | MOXIFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 1c6f7150-a8f4-408f-956f-c26d37030cf4 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | C53598599T |
| MOXIFLOXACIN | MOXIFLOXACIN | Redpharm Drug | 5e565825-8cca-8ddd-e063-6394a90a026a | 2026-10-21 | Warnings, Adverse reactions | C53598599T |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 4550K0SC9B |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 4550K0SC9B |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Braintree Laboratories, Inc. | 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | 2026-10-08 | Warnings, Adverse reactions | 0YPR65R21J |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Affordable Pharmaceuticals, LLC | f86bdcc8-e643-4160-89ae-01c89bee842d | 2026-10-08 | Warnings, Adverse reactions | 0YPR65R21J |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | dddd2701-4d46-44de-a9f8-303d4dcceef7 | 2026-10-08 | Warnings, Adverse reactions | 0YPR65R21J |
| MOXIFLOXACIN | MOXIFLOXACIN | Aurobindo Pharma Limited | 8877013d-9b49-40f7-a2c4-99bb519e104e | 2026-09-18 | Warnings, Adverse reactions | C53598599T |
| Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral | SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL | Macleods Pharmaceuticals Limited | e56e8f90-51f5-4f51-9b6b-a6f5a2e499cc | 2026-09-18 | Warnings, Adverse reactions | 0YPR65R21J |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | REMEDYREPACK INC. | 54377276-96bf-4140-9e90-55623ab6b013 | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | C53598599T |
| Pollutox | ACETONE, ARSENICUM ALBUM, BENZINUM, BERBERIS VULGARIS, CADMIUM SULPHURATUM, CARBON DIOXIDE, CARBONEUM SULPHURATUM, CHLORINUM, HYDROFLUORICUM ACIDUM, MELATONIN, MERCURIUS SOLUBILIS, NITROGENUM OXYGENATUM, NUX VOMICA, OZONE, PETROLEUM, PLUMBUM METALLICUM, STANNUM METALLICUM, SULPHURICUM ACIDUM, TOLUENE, URANIUM NITRICUM | Deseret Biologicals, Inc. | 741fdddf-75af-45a2-9875-ee3b08b0decf | 2026-09-08 | Warnings | O40UQP6WCF |
| BMNP Nat Sulph | NATRUM SULPHURICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a582af9-8c00-22af-e063-6394a90a0fa0 | 2026-08-31 | Warnings | 0YPR65R21J |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 0YPR65R21J |
| Moxifloxacin | MOXIFLOXACIN | Chartwell RX, LLC | 656f582c-ecba-4ec8-9420-9562114d889b | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | C53598599T |
| Hepatone | CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, LYCOPODIUM CLAVATUM, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS | Energique, Inc. | 51064a35-bf55-4905-a305-7b80a29417e9 | 2026-08-11 | Warnings | 0YPR65R21J |
| Aller-Chord A | ALFALFA, ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, BRYONIA (ALBA), CITRICUM ACIDUM, COUMARINUM, EUPHRASIA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, JUNIPERUS COMMUNIS, MUCOSA NASALIS SUIS, NATRUM SULPHURICUM, PHOSPHORUS, POTHOS FOETIDUS, PULSATILLA (VULGARIS), SOLIDAGO VIRGAUREA, SULPHUR, TANACETUM VULGARE, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE | Energetix Corporation | 09e89c92-112d-4320-9df5-b9f938bb9095 | 2026-08-11 | Warnings | 0YPR65R21J |
| Hepatic-Tone | CARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CITRICUM ACIDUM, CYSTEINUM, HEPAR SUIS, LEPTANDRA VIRGINICA, MAGNESIA MURIATICA, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS, QUASSIA (AMARA), TARAXACUM OFFICINALE | Energetix Corporation | d5f61f13-7e9f-4e46-8ad8-0336f36288df | 2026-08-11 | Warnings | 0YPR65R21J |
| Lipo-Chord | ACETICUM AC, ACETYLSAL AC, ADRENOCORTICOTROPHIN, ALUMINA, ARSENICUM ALB, BORAGO, CEANOTHUS, CHELIDONIUM MAJ, CHIONANTHUS, CHLORAMPHENICOLUM, CHLORPROMAZINUM, CHOLESTERINUM, CORTISONE ACETICUM, DAMIANA, FOLLICULINUM, FUMARICUM AC, KALI IOD, LYCOPODIUM, NAT SULPHURICUM, NUX VOM, OLEUM MORRHUAE, PETROLEUM, PHENACETINUM, PHOSPHORICUM AC, PHOSPHORUS, PLUMB MET, SACCHARUM OFF, SILICEA, TARAXACUM, THYROIDINUM. | Energetix Corporation | 5c83cbd5-46fb-48a0-a739-ff9c81e7129c | 2026-08-11 | Warnings | 0YPR65R21J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.